Skip to main content
SpringerLink
Log in

Impact of steatosis on perioperative outcome following hepatic resection

  • Published:
Journal of Gastrointestinal Surgery

Abstract

Fatty liver disease may interfere with liver regeneration and is postulated to result in an adverse outcome for patients subjected to partial hepatectomy. This study examines the impact of steatosis on outcome following hepatic resection for neoplasms. All patients with fatty livers (n = 325) who underwent hepatectomy between December 1991 and September 2001 were identified from a prospective database. Slides were reviewed and steatosis was quantified as follows: <30% (mild) and ≧30% (marked). Patient data were gathered and compared with results in 160 control patients with normal livers; subjects were matched for age, comorbidity, and extent of liver resection. There were 223 patients with mild and 102 with marked steatosis. Those with steatosis were more likely to be men (59% marked vs. 55% mild vs. 43% control; P = 0.01)withahigherbodymassindex(29.7± 5.5 marked vs. 28.2 ± 5.5 mild vs. 26.0 ± 5.4 control; P<0.01), and treated preoperatively with chemotherapy (66% marked vs. 55% mild vs. 38% control; P < 0.01). Total (62%, 48%, and 35%; P< 0.01) and infective (43%, 24%, and 14%; P< 0.01) complications correlated with the degree of steatosis. No difference was observed in complications requiring major medical intervention, hospitalization, or admission to the intensive care unit between groups. On multivariate analysis, steatosis was an independent predictor of complications (P< 0.01, risk ratio = 3.04, 95% confidence interval = 1.7 to 5.54). There was a nonsignificant trend toward higher 60-day mortality in patients with marked steatosis who had lobe or more resections (9.4% marked vs. 5.0% mild vs. 5.0% control; P = 0.30). Marked steatosis is an independent predictor of complications following hepatic resection but does not have a significant impact on 60-day mortality. Steatosis alone should not preclude aggressive hepatic resection for neoplasms when indicated; however, patients with marked steatosis undergoing large resections should still be approached with due caution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938–946.

    PubMed  CAS  Google Scholar 

  2. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790–799.

    Article  PubMed  CAS  Google Scholar 

  3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.

    Article  PubMed  CAS  Google Scholar 

  4. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, Youssef BM, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507–517.

    Article  PubMed  CAS  Google Scholar 

  5. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505–510.

    PubMed  CAS  Google Scholar 

  6. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: Comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000;232:557–569.

    Article  PubMed  CAS  Google Scholar 

  7. Harrison LE, Brennan MF, Newman E, Fortner JG, Picardo A, Blumgart LH, Fong Y. Hepatic resection for noncolorectal, nonneuroendocrine metastases: A fifteen-year experience with ninety-six patients. Surgery 1997;121:625–632.

    Article  PubMed  CAS  Google Scholar 

  8. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, BenPorat L, Little SA, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: Analysis of 1803 consecutive cases over the past decade. Ann Surg 2002;236:397–407.

    Article  PubMed  Google Scholar 

  9. MarosT, Seres-Sturm L, Lakatos O, Seres-Sturm M, Mody E, Blazsek V. Data regarding the restorative effects of the partial removal of the liver in advanced stages of toxic cirrhosis. Morphol Embryol (Bucur) 1975;21:213–217.

    Google Scholar 

  10. HaneyA, Peacock EE Jr, Madden JW. Liver regeneration and hepatic collagen deposition in rats with dimethylnitrosamineinduced cirrhosis. Ann Surg 1972;175:863–869.

    Article  Google Scholar 

  11. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995;130:198–203.

    PubMed  CAS  Google Scholar 

  12. Bismuth H, Chiche L, Adam R, Castaing D. Surgical treatment of hepatocellular carcinoma in cirrhosis: Liver resection or transplantation? Transplant Proc 1993;25:1066–1067.

    PubMed  CAS  Google Scholar 

  13. Hilden M, Christoffersen P, Juhl E, Dalgaard JB. Liver histology in a ’normal’ population—examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977;12:593–597.

    Article  PubMed  CAS  Google Scholar 

  14. Hornboll P, Olsen TS. Fatty changes in the liver: The relation to age, overweight and diabetes mellitus. Acta Pathol Microbiol Immunol Scand [A] 1982;90:199–205.

    CAS  Google Scholar 

  15. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811–816.

    Article  PubMed  CAS  Google Scholar 

  16. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990;12:1 106–1110.

    CAS  Google Scholar 

  17. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986;8:283–298.

    PubMed  CAS  Google Scholar 

  18. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–1231.

    Article  PubMed  CAS  Google Scholar 

  19. Li Z, Lin H, Yang S, Diehl AM. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 2002;123:1304–1310.

    Article  PubMed  CAS  Google Scholar 

  20. Diehl AM. Nonalcoholic steatosis and steatohepatitis. IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 2002;282:G1-G5.

    PubMed  CAS  Google Scholar 

  21. Bengmark S. Liver steatosis and liver resection. Digestion 1969;2:304–311.

    Article  PubMed  CAS  Google Scholar 

  22. Rao MS, Papreddy K, Abecassis M, Hashimoto T. Regeneration of liver with marked fatty change following partial hepatectomy in rats. Dig Dis Sci 2001;46:1821–1826.

    Article  PubMed  CAS  Google Scholar 

  23. SelznerM, Clavien PA. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway. Hepatology 2000;31:35–42.

    Article  Google Scholar 

  24. Zhang BH, Weltman M, Farrell GC. Does steatohepatitis impair liver regeneration. A study in a dietary model of nonalcoholic steatohepatitis in rats? J Gastroenterol Hepatol 1999;14:133–137.

    Article  PubMed  CAS  Google Scholar 

  25. Picard C, Lambotte L, Starkel P, Sempoux C, Saliez A, Van den Berge V, Horsmans Y. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol 2002;36:645–652.

    Article  PubMed  CAS  Google Scholar 

  26. Hayashi M, Fujii K, Kiuchi T, Uryuhara K, Kasahara M, Takatsuki M, Takeichi T, Kitade H, Sugimoto T, Uemoto S, Asonuma K, Egawa H, Fujita S, Inomata Y, Tanaka K. Effects of fatty infiltration of the graft on the outcome of livingrelated liver transplantation. Transplant Proc 1999;31:403.

    Article  PubMed  CAS  Google Scholar 

  27. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001;21:105–113.

    Article  PubMed  CAS  Google Scholar 

  28. Canelo R, Braun F, Sattler B, Klinge B, Lorf T, Ramadori G, Ringe B. Is a fatty liver dangerous for transplantation? Transplant Proc 1999;31:414–415.

    Article  PubMed  CAS  Google Scholar 

  29. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, Tzakis A, Starzl TE. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903–905.

    Article  PubMed  CAS  Google Scholar 

  30. D’Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, Pirsch JD, Hafez GR, Lorentzen D, Belzer FO. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 1991;23:1536–1537.

    PubMed  CAS  Google Scholar 

  31. Garrow JS, Webster J. Quetelet’s index (W/H2) as a measure of fatness. IntJ Obes 1985;9:147–153.

    CAS  Google Scholar 

  32. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097–1105.

    Article  PubMed  CAS  Google Scholar 

  33. Goldsmith N, Woodburne R. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet 1957;105:310–318.

    PubMed  CAS  Google Scholar 

  34. Martin RC, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg 2002;235:803–813.

    Article  PubMed  Google Scholar 

  35. Ploeg RJ, D’Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M. Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 1993;55:807–813.

    Article  PubMed  CAS  Google Scholar 

  36. Adam R, Reynes M, Johann M, Morino M, Astarcioglu I, Kafetzis I, Castaing D, Bismuth H. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991;23:1538–1540.

    PubMed  CAS  Google Scholar 

  37. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, LudwigJ, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292–298.

    Article  PubMed  CAS  Google Scholar 

  38. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000;191:38–46.

    Article  PubMed  CAS  Google Scholar 

  39. Little SA, Jarnagin WR, De Matteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 2002;6:88–94.

    Article  PubMed  Google Scholar 

  40. Zimmerman HJ. Liver disease caused by medicinal agents. Med Clin North Am 1975;59:897–907.

    PubMed  CAS  Google Scholar 

  41. Murata Y, Ogawa Y, Saibara T, Nishioka A, Fujiwara Y, Fukumoto M, Inomata T, Enzan H, Onishi S, Yoshida S. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. Oncol Rep 2000;7:1299–1304.

    PubMed  CAS  Google Scholar 

  42. Nemoto Y, Saibara T, Ogawa Y, Zhang T, Xu N, Ono M, Akisawa N, Iwasaki S, Maeda T, Onishi S. Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen. Intern Med 2002;41:345–350.

    PubMed  CAS  Google Scholar 

  43. ZeissJ, MerrickHW, Savolaine ER, WoldenbergLS, KimK, Schlembach PJ. Fatty liver change as a result of hepatic artery infusion chemotherapy. Am J Clin Oncol 1990;13:156–160.

    Article  Google Scholar 

  44. Peppercorn PD, Reznek RH, Wilson P, Slevin ML, Gupta RK. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 1998;77:2008–2011.

    PubMed  CAS  Google Scholar 

  45. HalonenP, Mattila J, Ruuska T, Salo MK, Makipernaa A. Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: Microvesicular fatty change and siderosis are the main findings. Med Pediatr Oncol 2003;40:148–154.

    Article  Google Scholar 

  46. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000; 174:160–171.

    Article  PubMed  CAS  Google Scholar 

  47. Yang SQ, Lin H, Lane M, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: Implications for pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997;94:2557–2562.

    Article  PubMed  CAS  Google Scholar 

  48. Loffreda S, Yang S, Lin H, Bulkley G, Bregman M, Nobel P, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57–65.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., 10021, New York, NY

    David A. Kooby M.D., Yuman Fong M.D., Peter J. Allen M.D., Ronald P. DeMatteo M.D., Michael D. Angelica M.D., Leslie H. Blumgart M.D. & William R. Jarnagin M.D.

  2. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York

    Mithat Gonen Ph.D.

  3. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York

    Arief Suriawinata M.D. & David S. Klimstra M.D.

Authors
  1. David A. Kooby M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuman Fong M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arief Suriawinata M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mithat Gonen Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter J. Allen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David S. Klimstra M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ronald P. DeMatteo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael D. Angelica M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Leslie H. Blumgart M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. William R. Jarnagin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William R. Jarnagin M.D..

Additional information

Supported in part by grant T32 CA 09501 from the National Institutes of Health (D.K.).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kooby, D.A., Fong, Y., Suriawinata, A. et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7, 1034–1044 (2003). https://doi.org/10.1016/j.gassur.2003.09.012

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.gassur.2003.09.012

Key words

Search

Navigation